...Jinyoung Jeong; Hyesu Jo; Jaeyu Park; Lee Smith; Masoud Rahmati; Kwanjoo Lee; Yeonjung Ha; Dong Keon Yon Introduction: Previous studies have suggested an association between vaccines and autoimmune diseases, but they were limited by their narrow focus and timeframe. Methods: This study conducted...

...Ruth-Helena Ramírez-Giraldo; Paola-Andrea Giraldo-Avila; Ana-Maria Calle; Luis-Carlos Santamaria; Jorge Sánchez Introduction: Egg allergy usually manifests during the initial 2 years of life, a period in which most vaccinations are administered. This often leads to delays in the application of some...

...Fiorella Petrelli; Daiana Giannini; Celestino Pucci; Isabella Del Corso; Valeria Rocchi; Maria Pia Dolcher; Giulio Pieve; Federico Pratesi; Paola Migliorini; Ilaria Puxeddu Introduction: Immediate and delayed hypersensitivity reactions (HSR) to COVID-19 vaccines are rare adverse events that need...

...Sudhir Gupta; Houfen Su; Sudhanshu Agrawal Introduction: In the trials of corona virus vaccines, detailed analyses of subsets of lymphocytes were not carried out. We present perhaps the most comprehensive immunological analysis of 29 subsets of B and T cells in 2 healthy subjects receiving 2 doses...

... the immune responses (including the innate and adaptive immunities) to SARS-CoV, MERS-CoV, and SARS-CoV-2, so as to improve our understanding of the concept of the COVID-19 disease, which will be helpful in developing vaccines and medications for treating the COVID-19 patients. The effective innate...

... therapeutic approaches are only supportive, have limited efficacy, and the prevention in reducing the transmission of SARS-CoV-2 virus is the best hope for public health. It is presumed that an effective vaccination against SARS-CoV-2 infection could mobilize the innate and adaptive immune responses...

... extract (CPE) containing 1.5-4.2 μg of Cry j 1 is currently the highest-concentration extract available for allergen-specific immunotherapy (SIT) against this pollinosis. Therefore, we developed a PEGylated fusion protein as a more effective SIT vaccine against Japanese cedar pollinosis. Methods...

... Immune response Skin scarification Vaccine National Institutes of Health (NIH) 10.13039/100000002 A main objective of this pilot study was to determine whether the administration of a protein antigen by skin scarification (SS) would induce immune responses in healthy subjects. SS...

... conjugates for the production of VT vaccine which induces protection against VTs. Verocytotoxin VT1 VT2 Protection VT-liposome Vaccine © 1997 S. Karger AG, Basel 1997 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...

...Margaret I. Johnston Because of a unique combination of challenges facing human immunodeficiency virus vaccine developers, a number of traditional and novel vaccine designs are being evaluated essentially in parallel. Monomeric proteins, poxvirus vectors, peptides, and particle-based candidate...

... in conferring protection against viral infections. Thus, while there is no risk of inducing infections in XLA patients by administering vaccines containing killed viruses or recombinant viral proteins, stimulation of T cell immunity by such vaccines may be of potential benefit particularly in the defense...

...-liposome conjugate for the development of a vaccine with the least allergic reaction and also for the application of immunotherapy. 16 03 1995 26 09 1995 4 9 2009 © 1996 S. Karger AG, Basel 1996 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. T. pallidum Recombinant treponemal antigens TmpA, TmpB Syphilis Vaccine Autoimmunity RIBI adjuvant Guinea pig Immune response Original Paper Int Arch Allergy...

...Christopher A. Coop; Synya K. Balanon; Kevin M. White; Bonnie A. Whisman; Melinda M. Rathkopf Background: Allergic reactions to the influenza vaccine are uncommon and usually associated with sensitivity to egg or gelatin. The aim of this study was to report the case of anaphylaxis to the influenza...

... Background: Recently, recombinant hypoallergenic derivatives of the major birch pollen allergen, Bet v 1, were used to treat birch-pollen-allergic patients in a double-blind, placebo-controlled, multi-centre immunotherapy study. The aim of this study was to evaluate the effects of vaccination with aluminium...

... Moingeon Background: We describe the production in Escherichia coli as a recombinant protein of clinical grade wild-type Bet v 1a (rBet v 1a), to be used as a candidate vaccine against birch pollen allergy. Methods: This recombinant protein was purified by hydrophobic interaction and ion exchange...

...: These results suggest that Stx-liposome conjugates may serve as candidate vaccines to induce protection against death caused by cytotoxin-producing E. coli infection. 2 5 2002 The monkeys received an intramuscular injection into the posterior femoral muscles with 1 ml of Stx2-liposome solution...

... immunization in SCID mice with Ttd increased the number of cases of resistance to Ttx. Conclusions: These results suggest that hu-PBL-SCID mice might serve as a tool for predicting the protective ability against pathogens in PBL donors and also for evaluating vaccine efficacy. PBL from a donor were injected...

... unresponsiveness Antigen–liposome conjugates Vaccine Cytokine Th1/Th2 Vaccines are currently regarded as the most efficient tool to control or eliminate severe infectious diseases. However, a number of reports have also described the unwanted side effects of vaccinations, including local swelling...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Allergy Vaccine IgE Mimotopes Phage display libraries References 1. Knutti–Müller JM, Stadler BM...